Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects
Angela Tomasovic, Theresa Brand, Constanze Schanbacher and 23 more
Nature Communications · 2020
doi:10.1038/s41467-020-15505-4 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
References76
40 more references, whose wording the paper’s licence keeps private.
All 76 referencesReads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.